HOME THERAPY AREAS A shift in focus: International insights into the optimal management of CKD-MBD 5 September 2022 Nephrology and Rare Diseases CKD-MBD and SHPT This CSL Vifor-sponsored educational symposium at the 59th European Renal Association (ERA) congress, chaired by Dr Marianne Rix, explores optimal management across the chronic kidney disease-mineral and bone disorder (CKD-MBD) continuum, including: Management challenges in secondary hyperparathyroidism (SHPT) and hyperphosphataemia Pertinent clinical and real-world data evaluating the treatment options for both diseases Patient perspectives via engaging patient case animations Practical approaches to CKD-MBD patient management Firstly, experts from the field, Prof James Wetmore and Prof Jan Kielstein, debate effective SHPT treatment strategies and ask ‘How high is high enough?’ in relation to vitamin D adequacy and PTH control. Following this, the symposium moves on to discussing dialysis patients with hyperphosphataemia in Prof Jürgen Floege’s presentation, in which optimal phosphate management is considered. Watch this exciting, multimedia symposium to keep up with the current discussions surrounding CKD-MBD management as we shift our focus to life-long management of non-dialysis and dialysis patients. THERE IS MORE HERE Specialist information is located in this area. In order to be able to see this, you must verify yourself as a healthcare professional. ?